Balanced news tone
News Sentiment
NTRA sentiment intelligence
Natera Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
88/100 classification confidence.
directly relevant articles
high-authority source matches
-3.4% over one week, +27.3% over four weeks, trend active, and materially above fair value.
Insider Sell: Rowan Chapman Sells Shares of Natera Inc (NTRA)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock
Daniel Rabinowitz, Natera Inc.'s Chief Legal Officer, sold 16,800 shares of company stock for approximately $4.57 million on July 1, 2026. This sale was conducted under a Rule 10b5-1 trading plan adopted in December 2025, leaving him with 172,294 shares. The transaction occurred
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 04:13
- Source
- Investing.com
Form 4 Natera Inc For: 6 July By Investing.com
This article from Investing.com reports on a Form 4 filing for Natera Inc. (NTRA) related to July 6th. The content primarily consists of financial market data, indices, commodity prices, and other news headlines from Investing.com, with the specific details of the Form 4 not expl
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 07 Jul 2026 02:14
- Source
- Investing.com Nigeria
Natera (NTRA) legal chief sells 16,800 shares under Rule 10b5-1 plan
Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NTRA), sold 16,800 shares of common stock through 12 separate open-market transactions on July 1, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025.
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 07 Jul 2026 02:10
- Source
- Stock Titan
Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 trading plan
Solomon Moshkevich, President of Clinical Diagnostics at Natera (NTRA), reported selling 3,000 shares of common stock on July 1, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in November 2024. The shares were sold in open-market transaction
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 07 Jul 2026 02:10
- Source
- Stock Titan
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock By Investing.com
Natera's Chief Legal Officer, Daniel Rabinowitz, sold 16,800 shares of company stock totaling approximately $4.57 million on July 1, 2026, through a pre-arranged trading plan. This sale occurred while Natera's stock is near its 52-week high and is considered overvalued according
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 07 Jul 2026 01:10
- Source
- Investing.com Australia
Board member Monica Bertagnolli exits Natera (NASDAQ: NTRA)
Monica Bertagnolli has resigned from Natera's Board of Directors and all associated committees, effective July 1, 2026. Her departure is attributed to a new position at the National Academy of Medicine and is not due to any disagreements with the company's operations, policies, o
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 20:10
- Source
- Stock Titan
Evercore Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $300
Evercore has reiterated its Buy rating on Natera (NTRA.US) and increased its price target for the company to $300. This adjustment reflects continued confidence in Natera's financial prospects and market position.
- Tone
- Positive 75/100
- Event
- Analyst action
- Published
- 06 Jul 2026 19:13
- Source
- Moomoo
Natera Inc focuses on genetic testing growth as investors watch Nasdaq trading
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- ad-hoc-news.de
Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
Why Natera (NTRA) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Have Natera Insiders Been Selling Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- simplywall.st
Goldman Sachs initiates Natera stock with Neutral rating, $245 target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 05 Jun 2026 07:00
- Source
- Investing.com
Keytruda developer and cancer center chief join Natera board
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Stock Titan
Natera And 2 Other Companies That May Be Trading Below Their Estimated Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
How The Natera (NTRA) Investment Story Is Shifting With New Guidance And Analyst Revisions
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 May 2026 07:00
- Source
- Market source
Is It Time To Reconsider Natera (NTRA) After Its Strong Five Year Share Price Gain
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- simplywall.st
Analysts Have Made A Financial Statement On Natera, Inc.'s (NASDAQ:NTRA) First-Quarter Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- simplywall.st
Natera (NTRA) Q4 Profit Of US$47.3 Million Tests Longstanding Loss‑Making Narrative
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Natera co-founder Sheena Jonathan sells $22,059 in common stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Investing.com
Vanguard Capital Management holds 7.21M Natera shares (NTRA) in Schedule 13G
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
William Blair initiates Natera stock with Outperform on growth outlook
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 13 Apr 2026 07:00
- Source
- Investing.com
What's Driving Natera's Recent Stock Action
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 04:42
- Source
- Kavout | AI
New Natera genome test targets faster answers for rare disease families
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Mar 2026 07:00
- Source
- Stock Titan
GeneDx stock falls as Natera launches competing rare disease test
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 12 Mar 2026 07:00
- Source
- Investing.com